发明名称 HUMAN INTERFERON beta-1alpha HYBRID POLYPEPTIDE, MUTANTS THEREOF AND DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF
摘要 1. A polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID Nos:45-59; and a hinge, CH2 and CH3 domains of an immunoglobulin. 2. The polypeptide of claim 1, wherein the immunoglobulin is a human immunoglobulin. 3. The polypeptide of claim 1, wherein the immunoglobulin is of the IgG class. 4. The polypeptide of claim 3, wherein the IgG is IgGl. 5. The polypeptide of claim 4, wherein comprises an amino acid sequence SEQ ID No:42 or 44. 6. The polypeptide of claim 1 in a glycosylated form. 7. Use a polypeptide of claim 1 for manufacturing a medicament for treating inflammatory, autoimmune, antiogene, tumor or virus diseases. 8. A polypeptide derivative of claim 1 comprising a polyalkylglycol polymer. 9. The derivative of claim 8, wherein the polyalkylglycol polymer is coupled to the N-terminus of the amino acid sequence of the polypeptide. 10. A pharmaceutical composition comprising a therapeutically effective amount of polypeptide of claim 1.
申请公布号 EA005005(B1) 申请公布日期 2004.10.28
申请号 EA20010000447 申请日期 1999.10.15
申请人 BIOGEN, INC. 发明人 WHITTY, ADRIAN;RUNKEL, LAURA;BRICKELMAIER, MARGOT;HOCHMAN, PAULA
分类号 C12N15/09;A61K38/00;A61K38/21;A61P9/00;A61P31/12;C07K14/565;C07K17/08;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/62;C12P21/02;(IPC1-7):C07K14/565;A61P35/00;A61P37/02 主分类号 C12N15/09
代理机构 代理人
主权项
地址